Invesco’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Invesco’s Portfolio HPTX Stock Details HPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-33,570	Closed	-$1.54M	–	4429
2015 Q1	$1.54M	Buy	+33,570	New	+$1M	﹤0.01%	2783
2014 Q4	–	Sell	-98,880	Closed	-$2.49M	–	4144
2014 Q3	$2.49M	Buy	98,880 +6,840	+7%	+$170K	﹤0.01%	2405
2014 Q2	$2.4M	Buy	92,040 +84,122	+1,062%	+$2.16M	﹤0.01%	2454
2014 Q1	$204K	Buy	7,918 +2,932	+59%	+$79.4K	﹤0.01%	3733
2013 Q4	$101K	Buy	+4,986	New	+$117K	﹤0.01%	4021

Invesco's HPTX Position: Q2 2015 in Review

Invesco sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 33,570 shares — an estimated $1.54M sold.

Invesco first reported a position in HPTX in Q4 2013 and held it in 5 quarters. The position peaked at $2.49M in Q3 2014. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

Invesco reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Invesco sold 33,570 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $1.54M.
Invesco first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q4 2013 and held it in 5 quarters.
Invesco's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $2.49M in Q3 2014.
0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Invesco's 13F filing for Q2 2015, filed 14 Aug 2015.